home / stock / nymx / nymx quote
Last: | $0.20 |
---|---|
Change Percent: | 11.65% |
Open: | $0.22 |
Close: | $0.20 |
High: | $0.22 |
Low: | $0.1827 |
Volume: | 877,543 |
Last Trade Date Time: | 07/06/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2 | $0.22 | $0.2 | $0.22 | $0.1827 | 877,543 | 07-06-2023 |
$0.249 | $0.2619 | $0.249 | $0.27 | $0.2222 | 429,017 | 07-05-2023 |
$0.2619 | $0.19 | $0.19 | $0.35 | $0.1855 | 3,432,443 | 07-04-2023 |
$0.2619 | $0.19 | $0.2619 | $0.35 | $0.1855 | 3,432,443 | 07-03-2023 |
$0.19 | $0.2085 | $0.19 | $0.2212 | $0.1688 | 243,643 | 06-30-2023 |
$0.215 | $0.28 | $0.215 | $0.2819 | $0.2023 | 470,327 | 06-29-2023 |
$0.2816 | $0.31 | $0.2816 | $0.33 | $0.2816 | 158,894 | 06-28-2023 |
$0.31 | $0.35 | $0.31 | $0.35 | $0.31 | 70,591 | 06-27-2023 |
$0.3329 | $0.34 | $0.3329 | $0.35 | $0.315 | 45,635 | 06-26-2023 |
$0.3193 | $0.357 | $0.3193 | $0.3669 | $0.3193 | 107,230 | 06-23-2023 |
$0.3499 | $0.37 | $0.3499 | $0.37 | $0.3457 | 51,822 | 06-22-2023 |
$0.3801 | $0.36 | $0.3801 | $0.414 | $0.36 | 27,643 | 06-21-2023 |
$0.3789 | $0.371 | $0.3789 | $0.4099 | $0.371 | 40,721 | 06-20-2023 |
$0.376 | $0.417 | $0.376 | $0.417 | $0.376 | 17,695 | 06-19-2023 |
$0.376 | $0.417 | $0.376 | $0.417 | $0.376 | 17,695 | 06-16-2023 |
$0.3857 | $0.39 | $0.3857 | $0.4139 | $0.375 | 38,827 | 06-15-2023 |
$0.378 | $0.3921 | $0.378 | $0.3999 | $0.371 | 6,252 | 06-14-2023 |
$0.373 | $0.38 | $0.373 | $0.3819 | $0.371 | 44,039 | 06-13-2023 |
$0.3882 | $0.38 | $0.3882 | $0.4169 | $0.38 | 19,005 | 06-12-2023 |
$0.3901 | $0.3988 | $0.3901 | $0.3988 | $0.39 | 33,395 | 06-09-2023 |
News, Short Squeeze, Breakout and More Instantly...
Nymox Pharmaceutical Corporation Company Name:
NYMX Stock Symbol:
NASDAQ Market:
Nymox Pharmaceutical Corporation Website:
IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq,...
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a mid-2nd quarter update on ongoing activities. The Company reported last month that it expects to submit an additional new submission for marketing...
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a current update on the Company's ongoing projects. The Company recently submitted its application for Marketing Authorization Application to the ...